Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ALIMENTARY PHARMACOLOGY & THERAPEUTICS(2017)